The Vanderbilt Vaccine Research Program received NIH grant to continue work as Vaccine and Treatment Evaluation

,

On Jan. 23, 2020, the Vanderbilt Vaccine Research Program (VVRP) received a grant from the National Institutes of Health (NIH) to continue its work as one of the nationﾒs nine Vaccine and Treatment Evaluation Units (VTEUs).

Tags:

Source: VUMC Reporter
Credit:

Visit News/History Source
Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.